Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase NA 1Phase 3 1

Status

Completed 4Terminated 2Unknown 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 1

Conditions

Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × epratuzumab × Clear all
NCT00301821 2019-10-09

Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Alliance for Clinical Trials in Oncology

Phase 2 Completed
107 enrolled 8 charts
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00945815 2017-11-06

S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

SWOG Cancer Research Network

Phase 2 Completed
35 enrolled 7 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00553501 2016-07-06

Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Alliance for Clinical Trials in Oncology

Phase 2 Completed
60 enrolled 7 charts
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00044902 2007-12-28

Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

Amgen

Phase 2 Completed
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡